These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23944028)
21. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration. Li N; Je YJ; Yang M; Jiang XH; Ma JH Pharmazie; 2011 May; 66(5):374-7. PubMed ID: 21699072 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics of flavonoids from xiexin decoction in rats]. Yan JC; Liu ZM; Wang TM; Shi R; Ma YM Yao Xue Xue Bao; 2007 Jul; 42(7):722-9. PubMed ID: 17882955 [TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacokinetics of baicalin in plasma after oral administration of Huang-Lian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats. Zeng MF; Pan LM; Zhu HX; Zhang QC; Guo LW Fitoterapia; 2010 Sep; 81(6):490-6. PubMed ID: 20093170 [TBL] [Abstract][Full Text] [Related]
24. Study on the bioavailability of baicalin-phospholipid complex by using HPLC. Wu J; Chen D; Zhang R Biomed Chromatogr; 1999 Nov; 13(7):493-5. PubMed ID: 10534761 [TBL] [Abstract][Full Text] [Related]
25. Increased oral AUC of baicalin in streptozotocin-induced diabetic rats due to the increased activity of intestinal beta-glucuronidase. Liu L; Deng YX; Liang Y; Pang XY; Liu XD; Liu YW; Yang JS; Xie L; Wang GJ Planta Med; 2010 Jan; 76(1):70-5. PubMed ID: 19639536 [TBL] [Abstract][Full Text] [Related]
26. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980 [TBL] [Abstract][Full Text] [Related]
27. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization. Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976 [TBL] [Abstract][Full Text] [Related]
28. [Study on stability of baicalin and baicalein in Rat plasma by HPLC-ECD]. Wang Q; Zhang YJ; Li WF; Yang J; Jiang H; Sun WJ Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2675-8. PubMed ID: 19216170 [TBL] [Abstract][Full Text] [Related]
29. Gradient high-performance liquid chromatography for the simultaneous determination of chlorogenic acid and baicalin in plasma and its application in the study of pharmacokinetics in rats. Gao R; Zheng Q; Gong T; Fu Y; Deng L; Zhang ZR J Pharm Biomed Anal; 2007 Jan; 43(1):335-40. PubMed ID: 16859859 [TBL] [Abstract][Full Text] [Related]
30. D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions. Yue PF; Wan J; Wang Y; Li Y; Ma YQ; Yang M; Hu PY; Yuan HL; Wang CH Int J Pharm; 2013 Feb; 443(1-2):279-87. PubMed ID: 23291447 [TBL] [Abstract][Full Text] [Related]
31. Acupuncture can improve absorption of baicalin from extracts of Scutellaria baicalensis Georgi in rats. Zhou J; Qu F; Burrows E; Yu Y; Nan R Phytother Res; 2009 Oct; 23(10):1415-20. PubMed ID: 19274704 [TBL] [Abstract][Full Text] [Related]
32. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability. Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197 [TBL] [Abstract][Full Text] [Related]
33. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
34. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation. Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446 [TBL] [Abstract][Full Text] [Related]
35. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetic comparison of baicalin absorption medicine Qinbai Qingfei concentrated pellets drug compatibility]. Li HL; Feng WC; Yao L; Sun Y; Song YJ; Hu H; Wang WM Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1933-6. PubMed ID: 25282909 [TBL] [Abstract][Full Text] [Related]
37. Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin. Kang MJ; Ko GS; Oh DG; Kim JS; Noh K; Kang W; Yoon WK; Kim HC; Jeong HG; Jeong TC Arch Pharm Res; 2014 Mar; 37(3):371-8. PubMed ID: 23771520 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetic study on baicalin of Qingkailing injection in rats]. Xiao L; Wang F; Li HD; Zhao XY Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2534-8. PubMed ID: 18330252 [TBL] [Abstract][Full Text] [Related]
39. Ursodeoxycholic acid pretreatment reduces oral bioavailability of the multiple drug resistance-associated protein 2 substrate baicalin in rats. Wu T; Li XP; Xu YJ; Du G; Liu D Planta Med; 2013 Nov; 79(17):1615-9. PubMed ID: 24135887 [TBL] [Abstract][Full Text] [Related]
40. Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole. Sun Y; Chen D; Zhao Y; Zhou K; Zhang B; Wang H; Xie S Drug Deliv Transl Res; 2022 May; 12(5):1219-1229. PubMed ID: 34148210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]